Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / VTGN - VistaGen Therapeutics' (VTGN) CEO Shawn Singh on Q2 2022 Results - Earnings Call Transcript

VTGN - VistaGen Therapeutics' (VTGN) CEO Shawn Singh on Q2 2022 Results - Earnings Call Transcript

VistaGen Therapeutics Inc.
VistaGen Therapeutics, Inc. (VTGN) Q2 2022 Earnings Conference Call November 10, 2021 5:00 PM ET Company Participants Mark Flather – Vice President of Investor Relations Shawn Singh – Chief Executive Officer Jerry Dotson – Chief Financial Officer Mark Smith – Chief Medical Officer Conference Call Participants Brian Skorney – Robert W. Baird Tim Lugo – William Blair Jason McCarthy – Maxim Group Andrew Tsai – Jefferies Presentation Operator Greetings, and welcome to VistaGen Therapeutic Second Quarter of Fiscal Year 2022 Results Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host Mark Flather, Vice President of Investor Relations. Thank you. You may begin. Mark Flather Thank you, Doug. Hello and welcome to VistaGen's conference call covering its fiscal year 2022 second

For further details see:

VistaGen Therapeutics' (VTGN) CEO Shawn Singh on Q2 2022 Results - Earnings Call Transcript
Stock Information
Company Name: VistaGen Therapeutics Inc.
Stock Symbol: VTGN
Market: NASDAQ
Website: vistagen.com
Menu
VTGN VTGN Quote VTGN Short VTGN News VTGN Articles VTGN Message Board
Get VTGN Alerts

News, Short Squeeze, Breakout and More Instantly...